[HTML][HTML] Key topics in molecular docking for drug design

PHM Torres, ACR Sodero, P Jofily… - International journal of …, 2019 - mdpi.com
Molecular docking has been widely employed as a fast and inexpensive technique in the
past decades, both in academic and industrial settings. Although this discipline has now had …

[HTML][HTML] Empirical scoring functions for structure-based virtual screening: applications, critical aspects, and challenges

IA Guedes, FSS Pereira, LE Dardenne - Frontiers in pharmacology, 2018 - frontiersin.org
Structure-based virtual screening (VS) is a widely used approach that employs the
knowledge of the three-dimensional structure of the target of interest in the design of new …

[HTML][HTML] New machine learning and physics-based scoring functions for drug discovery

IA Guedes, AMS Barreto, D Marinho, E Krempser… - Scientific reports, 2021 - nature.com
Scoring functions are essential for modern in silico drug discovery. However, the accurate
prediction of binding affinity by scoring functions remains a challenging task. The …

Highly flexible ligand docking: Benchmarking of the DockThor program on the LEADS-PEP protein–peptide data set

KB Santos, IA Guedes, ALM Karl… - Journal of Chemical …, 2020 - ACS Publications
Protein–peptide interactions play a crucial role in many cellular and biological functions,
which justify the increasing interest in the development of peptide-based drugs. However …

[HTML][HTML] Scoring functions for protein-ligand binding affinity prediction using structure-based deep learning: a review

R Meli, GM Morris, PC Biggin - Frontiers in bioinformatics, 2022 - frontiersin.org
The rapid and accurate in silico prediction of protein-ligand binding free energies or binding
affinities has the potential to transform drug discovery. In recent years, there has been a …

[HTML][HTML] Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants

IA Guedes, LSC Costa, KB Dos Santos, ALM Karl… - Scientific Reports, 2021 - nature.com
The COVID-19 caused by the SARS-CoV-2 virus was declared a pandemic disease in
March 2020 by the World Health Organization (WHO). Structure-Based Drug Design …

Proximity ranking-based multimodal differential evolution

J Zhang, D Chen, Q Yang, Y Wang, D Liu… - Swarm and Evolutionary …, 2023 - Elsevier
Multimodal optimization aiming at locating multiple global optima at a time has received
extensive attention from researchers since it can afford multiple choices for decision-makers …

[HTML][HTML] Atherosclerosis fate in the era of tailored functional foods: Evidence-based guidelines elicited from structure-and ligand-based approaches

L Azevedo, MSM Serafim, VG Maltarollo… - Trends in Food Science …, 2022 - Elsevier
Background Atherosclerosis is the primary cause of cardiovascular diseases (CVDs),
contributing to more than 33% of the annual deaths globally. Westernized dietary patterns, a …

Ligand and structure-based Virtual Screening Applied to the SARS-CoV-2 Main Protease: an In Silico Repurposing Study

WR Ferraz, RA Gomes, AL S Novaes… - Future medicinal …, 2020 - Taylor & Francis
Aim: The identification of drugs for the coronavirus disease-19 pandemic remains urgent. In
this manner, drug repurposing is a suitable strategy, saving resources and time normally …

Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study

A Nag, R Banerjee, S Paul, R Kundu - Computers in Biology and Medicine, 2022 - Elsevier
Abstract Background Omicron (B. 1.1. 529), a variant of SARS-CoV-2 is currently spreading
globally as a dominant strain. Due to multiple mutations at its Spike protein, including 15 …